2024 Global Viral And Non-Viral Vector Manufacturing Market Report: Key Drivers, Size, and Leading Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Predicted for the Viral And Non-Viral Vector Manufacturing Market for 2024-2033?
In recent years, the size of the viral and non-viral vector manufacturing market has notably expanded. The market is projected to increase from $7.22 billion in 2023 to $8.62 billion in 2024, with a compound annual growth rate (CAGR) of 19.5%. This growth in the historical period is due to several factors, including the increased occurrence of genetic disorders, advancements in biotech, more investment in gene therapy research, heightened awareness of personalized medicine, and regulatory backing for gene therapy development.
The market for viral and non-viral vector manufacturing is projected to witness swift expansion in the upcoming years. The market is predicted to reach a value of $17.85 billion by 2028, growing at a compounded annual growth rate (CAGR) of 20.0%. This projected growth during the forecast period is credited to a surge in demand for gene therapies, the widening scope in the treatment of rare ailments, an increase in biomanufacturing infrastructure investment, and the rising adoption of precision medical practices. The forecast period is also expected to see several trends like the creation of next-generation viral vectors, heightened application of crispr/cas9 technology for vector production, emphasis on scalable and affordable manufacturing methods, rising use of non-viral vectors, and developments in cell and gene therapy manufacturing techniques.
Claim Your Free Sample of the Global Viral And Non-Viral Vector Manufacturing Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12570&type=smp
What Drivers Are Enhancing the viral and non-viral vector manufacturing Market’s Growth?
The growth of viral and non-viral vector production markets is anticipated to be fuelled by the escalating incidence of genetic disorders. These disorders often stem completely or partially from anomalies in the normal DNA sequence. Viral vectors function by carrying therapeutic genes to the cells that are targeted, taking the place of, or supplementing faulty genes that give rise to genetic disorders. On the other hand, non-viral vectors come into play predominantly during ex vivo gene therapy methods, in circumstances where cells are genetically altered outside the body before being reintroduced into the patient. For example, Versus Arthritis, a UK-based charity committed to aiding people with arthritis disclosed in June 2023 that around 450,000 individuals will suffer from rheumatoid arthritis, 190,000 adults will develop psoriatic arthritis, and about 10 million will have osteoarthritis in 2021. In comparison, the figures for 2021 were 430,000 people with rheumatoid arthritis, 100,000 adults with psoriatic arthritis, and 8.5 million with osteoarthritis. Moreover, as per June 2022 records from the International Diabetes Federation, a Belgium-based diabetes federation, diabetes prevalence had escalated to 10.5% internationally, with over half (44.7%) of these people remaining undiagnosed and approximately 783 million adults, or one in every eight people, predicted to have diabetes by 2045. Hence, the rising occurrence of genetic disorders propels the growth of the viral and non-viral vector manufacturing market.
What Segments Are Central to the Viral And Non-Viral Vector Manufacturing Market?
1) By Vector Type: Viral Vector, Non-Viral Vector
2) By Disease: Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases
3) By Application: Gene Therapy, Vaccinology, Cell Therapy, Other Applications
What Emerging Trends Are Influencing Viral And Non-Viral Vector Manufacturing Industry Dynamics?
Technological progress is becoming a prevalent trend in the sectors of viral and non-viral vector manufacturing. To maintain their market position, primary businesses in these sectors are evolving with technologically advanced solutions. An example of this is Merck KGaA, a Germany-based company specializing in science and technology, which launched the VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform in August 2022. As one of the first to provide a comprehensive viral vector production package, including AAV, Lentiviral, CDMO, CTO, and process development, this technology has the potential to significantly reduce process development time and costs for biopharmaceutical companies, thereby speeding up the timeline for clinical production.
Order Now for Fast Delivery of Your Viral And Non-Viral Vector Manufacturing Market Report!
Which Geographic Locations Are Critical to the Growth of the Viral And Non-Viral Vector Manufacturing Market?
North America was the largest region in the viral and non-viral vector manufacturing market in 2023. The regions covered in the viral and non-viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Viral And Non-Viral Vector Manufacturing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the viral and non-viral vector manufacturing market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Viral And Non-Viral Vector Manufacturing Market Include
1. Viral And Non-Viral Vector Manufacturing Market Executive Summary
2. Viral And Non-Viral Vector Manufacturing Market Segments
3. Viral And Non-Viral Vector Manufacturing Market Size And Template Market Growth Rate
4. Key Viral And Non-Viral Vector Manufacturing Market Trends
5. Major Viral And Non-Viral Vector Manufacturing Market Drivers
……
25. Key Mergers And Acquisitions In The Viral And Non-Viral Vector Manufacturing Market
26. Top Viral And Non-Viral Vector Manufacturing Companies
27. Viral And Non-Viral Vector Manufacturing Market Opportunities And Strategies
28. Viral And Non-Viral Vector Manufacturing Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Viral Inactivation Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report
Viral Gastroenteritis Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report
Viral Vector Manufacturing Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
